Clinical Trial Detail
| NCT ID | NCT03012321 |
| Title | Abiraterone Acetate, Olaparib, and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer With DNA Repair Defects |
| Recruitment | Recruiting |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Northwestern University |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |
CKB BOOST